Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Financial Flexibility Index
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd financial flexibility index. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) has a Financial Flexibility Index of 0.05x as of December 2025. Free cash flow of CN¥2.18 Billion (operating CF CN¥1.84 Billion minus capex CN¥330.65 Million) represents 0% of total liabilities (CN¥43.39 Billion). See cash generation quality of Guangzhou Baiyunshan Pharmaceutical Hold to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (2000–2025)
Financial flexibility index of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd from 2000 to 2025. Historical Financial Flexibility Index trend for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd across 26 annual periods. Check 600332 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Financial Flexibility Index by Year (2000–2025)
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd financial flexibility index by year from 2000 to 2025. Year-by-year free cash flow to debt coverage for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd. For the full cash flow conversion analysis, see cash flow conversion of Guangzhou Baiyunshan Pharmaceutical Hold.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.03x | CN¥1.50 Billion | CN¥260.23 Million | CN¥43.39 Billion | ▼ -66.8% |
| 2024 | 0.10x | CN¥4.57 Billion | CN¥3.44 Billion | CN¥43.91 Billion | ▼ -23.9% |
| 2023 | 0.14x | CN¥5.73 Billion | CN¥4.10 Billion | CN¥41.91 Billion | ▼ -33.1% |
| 2022 | 0.20x | CN¥8.38 Billion | CN¥7.00 Billion | CN¥41.03 Billion | ▲ +2.6% |
| 2021 | 0.20x | CN¥6.93 Billion | CN¥5.67 Billion | CN¥34.79 Billion | ▲ +329.9% |
| 2020 | 0.05x | CN¥1.46 Billion | CN¥585.19 Million | CN¥31.55 Billion | ▼ -80.7% |
| 2019 | 0.24x | CN¥7.42 Billion | CN¥5.02 Billion | CN¥30.90 Billion | ▲ +19.5% |
| 2018 | 0.20x | CN¥5.70 Billion | CN¥5.22 Billion | CN¥28.34 Billion | ▼ -10.4% |
| 2017 | 0.22x | CN¥2.03 Billion | CN¥1.83 Billion | CN¥9.05 Billion | ▼ -30.8% |
| 2016 | 0.32x | CN¥2.67 Billion | CN¥2.44 Billion | CN¥8.24 Billion | ▼ -5.2% |
| 2015 | 0.34x | CN¥2.46 Billion | CN¥1.94 Billion | CN¥7.19 Billion | ▲ +1.1% |
| 2014 | 0.34x | CN¥2.12 Billion | CN¥1.76 Billion | CN¥6.25 Billion | ▲ +4.7% |
| 2013 | 0.32x | CN¥1.69 Billion | CN¥1.34 Billion | CN¥5.23 Billion | ▲ +16.3% |
| 2012 | 0.28x | CN¥559.14 Million | CN¥506.53 Million | CN¥2.01 Billion | ▲ +319.3% |
| 2011 | -0.13x | CN¥-121.19 Million | CN¥-180.05 Million | CN¥956.09 Million | ▼ -167.7% |
| 2010 | 0.19x | CN¥156.37 Million | CN¥73.17 Million | CN¥835.05 Million | ▼ -70.8% |
| 2009 | 0.64x | CN¥526.95 Million | CN¥439.39 Million | CN¥820.92 Million | ▲ +337.0% |
| 2008 | 0.15x | CN¥133.09 Million | CN¥6.10 Million | CN¥905.99 Million | ▼ -14.2% |
| 2007 | 0.17x | CN¥498.43 Million | CN¥375.74 Million | CN¥2.91 Billion | ▲ +224.9% |
| 2006 | 0.05x | CN¥129.33 Million | CN¥38.88 Million | CN¥2.46 Billion | ▼ -55.4% |
| 2005 | 0.12x | CN¥270.68 Million | CN¥146.32 Million | CN¥2.29 Billion | ▼ -40.9% |
| 2004 | 0.20x | CN¥509.23 Million | CN¥200.54 Million | CN¥2.55 Billion | ▲ +17.1% |
| 2003 | 0.17x | CN¥360.35 Million | CN¥-6.83 Million | CN¥2.11 Billion | ▼ -12.8% |
| 2002 | 0.20x | CN¥342.71 Million | CN¥169.01 Million | CN¥1.75 Billion | ▼ -7.9% |
| 2001 | 0.21x | CN¥300.59 Million | CN¥140.15 Million | CN¥1.41 Billion | ▼ -26.1% |
| 2000 | 0.29x | CN¥450.48 Million | CN¥286.95 Million | CN¥1.57 Billion | — |